154 related articles for article (PubMed ID: 29763278)
1. Implantable Buprenorphine (Probuphine) for Maintenance Treatment of Opioid Use Disorder.
Goodbar NH; Hanlon KE
Am Fam Physician; 2018 May; 97(10):668-670. PubMed ID: 29763278
[No Abstract] [Full Text] [Related]
2. Buprenorphine implants (Probuphine) for opioid dependence.
Med Lett Drugs Ther; 2016 Jul; 58(1499):94-5. PubMed ID: 27403784
[No Abstract] [Full Text] [Related]
3. Transdermal buprenorphine patch: Potential for role in management of opioid dependence.
Dhawan A; Modak T; Sarkar S
Asian J Psychiatr; 2019 Feb; 40():88-91. PubMed ID: 30772733
[TBL] [Abstract][Full Text] [Related]
4. Medication-Assisted Treatment of Opioid Use Disorder in Adolescents and Young Adults.
Cottrill CB; Matson SC
Adolesc Med State Art Rev; 2014 Aug; 25(2):251-65. PubMed ID: 27132312
[No Abstract] [Full Text] [Related]
5. Buprenorphine MAT as an Imperfect Fix.
Mund B; Stith K
J Law Med Ethics; 2018 Jun; 46(2):279-291. PubMed ID: 30147005
[TBL] [Abstract][Full Text] [Related]
6. Buprenorphine Treatment for Opioid Use Disorder: An Overview.
Shulman M; Wai JM; Nunes EV
CNS Drugs; 2019 Jun; 33(6):567-580. PubMed ID: 31062259
[TBL] [Abstract][Full Text] [Related]
7. Buprenorphine implants in medical treatment of opioid addiction.
Chavoustie S; Frost M; Snyder O; Owen J; Darwish M; Dammerman R; Sanjurjo V
Expert Rev Clin Pharmacol; 2017 Aug; 10(8):799-807. PubMed ID: 28571505
[TBL] [Abstract][Full Text] [Related]
8. Nalmefene Mistakenly Prescribed to Reduce Alcohol Consumption in Patients Under Buprenorphine Substitution Therapy Resulting in Acute Opioid Withdrawal: Management in an Emergency Setting.
Pélissier F; Rougé Bugat ME; Nubukpo P; Franchitto N
J Clin Psychopharmacol; 2016 Feb; 36(1):100-3. PubMed ID: 26658085
[No Abstract] [Full Text] [Related]
9. Pharmacology Update: Probuphine: The Long-Acting Buprenorphine Implant.
Lorman WJ
J Addict Nurs; 2019; 30(2):123-124. PubMed ID: 31162216
[No Abstract] [Full Text] [Related]
10. Treating prescription opioid dependence.
Ruetsch C
JAMA; 2014 Sep; 312(11):1145-6. PubMed ID: 25226480
[No Abstract] [Full Text] [Related]
11. Medications for Opioid Use Disorder: A Guide for Physicians.
Azhar N; Chockalingam R; Azhar A
Mo Med; 2020; 117(1):59-64. PubMed ID: 32158052
[TBL] [Abstract][Full Text] [Related]
12. Prescription opioid dependence: the clinical challenge.
Newman RG
JAMA Psychiatry; 2014 Mar; 71(3):338. PubMed ID: 24599244
[No Abstract] [Full Text] [Related]
13. Food and Drug Administration approval of sustained-release buprenorphine for treatment of opioid dependence: realizing its potential.
Sigmon SC; Bigelow GE
Addiction; 2017 Mar; 112(3):386-387. PubMed ID: 27561982
[No Abstract] [Full Text] [Related]
14. Once-monthly subcutaneous buprenorphine (Sublocade) for opioid use disorder.
Med Lett Drugs Ther; 2018 Feb; 60(1541):35-37. PubMed ID: 29485976
[No Abstract] [Full Text] [Related]
15. Efficacy and safety of a sublingual buprenorphine/naloxone rapidly dissolving tablet for the treatment of adults with opioid dependence: A randomized trial.
Webster L; Hjelmström P; Sumner M; Gunderson EW
J Addict Dis; 2016; 35(4):325-338. PubMed ID: 27267785
[TBL] [Abstract][Full Text] [Related]
16. New developments in managing opioid addiction: impact of a subdermal buprenorphine implant.
Itzoe M; Guarnieri M
Drug Des Devel Ther; 2017; 11():1429-1437. PubMed ID: 28546740
[TBL] [Abstract][Full Text] [Related]
17. Perioperative Management and Analgesia for Patients Taking Buprenorphine and Other Forms of Medication-Assisted Treatment for Substance Abuse Disorders.
Scholzen E; Zeng AM; Schroeder KM
Adv Anesth; 2019 Dec; 37():65-86. PubMed ID: 31677660
[No Abstract] [Full Text] [Related]
18. Why 24 State and Territorial Health Officials Support Buprenorphine Deregulation.
Stancliff S; Greene D; Zucker HA
Am J Public Health; 2019 Dec; 109(12):1678-1679. PubMed ID: 31693402
[No Abstract] [Full Text] [Related]
19. Defining Discontinuation for Buprenorphine Treatment: Implications for Quality Measurement.
Williams AR; Mauro CM; Huber B; Chiodo L; Crystal S; Samples H; Olfson M
Am J Psychiatry; 2024 May; 181(5):457-459. PubMed ID: 38706334
[No Abstract] [Full Text] [Related]
20. Novel Long-Acting Buprenorphine Medications for Opioid Dependence: Current Update.
Soyka M
Pharmacopsychiatry; 2021 Jan; 54(1):18-22. PubMed ID: 33212514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
